 LOS ANGELES, May 12, 2021 GLOBE NEWSWIRE -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced the release of preliminary data relating to the use of a novel cell therapy approach in controlling human immunodeficiency virus HIV in humans. Dr. Serhat Gumrukçu, co-founder and inventor of Enochian BioSciences and Director of the Seraph Research Institute SRI, presented the findings at the Annual Meeting of the American Society of Gene and Cell Therapy ASGCT. Presentation can be found at 